GNC / GLC Active Projects

Global NASH Council & Global Liver Council

33 Active Research Projects

SURVEY PROJECTS

Project Title and DescriptionStatusProject Director
4Pediatric MASLD Knowledge Survey
Survey of pediatric hepatologists/gastroenterologists and general pediatricians across the world in managing MASLD.
Actively EnrollingJillian Price
jillian.price@cldq.org
3Africa Sub Committee: survey to determine knowledge and resource needs
Survey to determine knowledge and resource needs for managing MASLD in different countries in Africa.
Actively EnrollingN/A
2Hepatitis B & D provider survey
Assessment of practice patterns in managing HBV and HDV in different regions of the world.
Enrollment Closed
in Analyses
Linda Henry
linda.henry@cldq.org
1ALD Stigma Survey: patient and provider surveys
Assessment of ALD-related stigma issues from both patients and providers (hepatologists, gastroenterologists and others) across all regions of the world.
Actively EnrollingFatema Nader
fatema.nader@cldq.org

PROSPECTIVE REGISTRIES

Project Title and DescriptionStatusProject Director
6Collaboration with King Faisal Specialist Hospital & Research Centre
Established a strategic collaboration with King Faisal Specialist Hospital & Research Centre, resulting in the submission of multiple joint scientific abstracts and the development of several collaborative research projects focused on MASLD and other metabolic diseases affecting the liver. Through the Global NASH Council (GNC) and the Center for Outcomes Research in Liver Disease (CORLD), we also supported the implementation of the Global Liver Registry within the hospital and other healthcare systems in SA using the REDCap platform integrated into their institutional infrastructure.
Actively EnrollingFatema Nader
fatema.nader@cldq.org
5Global Liver Registry: Prospective enrollment of 5 liver diseases (MASLD/MASH, HCV, HBV, PBC and ALD) across 30 clinical centers around the globe
Prospective enrollment of patients with 5 liver diseases (MASLD/MASH, HCV, HBV, PBC and ALD) across 30 clinical centers around the globe to assess clinical characteristics, laboratory data, PROs and long-term outcomes. These patients are enrolled and followed on an annual basis.
Actively EnrollingFatema Nader
fatema.nader@cldq.org

CME EDUCATIONAL INITIATIVES

Project Title and DescriptionStatusProject Director
7MASH Alliance Program: 10 regional city series across the US
Comprehensive educational program targeted at providers (gastroenterologists, hepatologists, endocrinologists, primary care physicians and their advanced practitioners) to understand the burden of MASLD, risk stratification algorithms and management. These programs are implemented by CLDF.
ActiveFatema Nader
fatema.nader@cldq.org

Global - MASLD Projects

Project Title and DescriptionStatusProject Director
18G-MASLD: MASLD and IBD
Assessment of overlap between MASLD and inflammatory bowel disease.
Actively EnrollingMarkos Kalligeros
17G-MASLD: Post-Transplant for MASLD/MASH: A Global Study
Assessment of characteristics and outcomes of liver transplant for MASLD, MetALD and ALD. The data are being collected retrospectively from transplant sites across the globe.
Actively EnrollingLinda Henry
linda.henry@cldq.org
16G-MASLD: MASLD and Viral Hepatitis and HIV Project
Assessment of overlap between MASLD and HBV, HCV, HDV and HIV infection.
Actively EnrollingMargarita Papatheodori
15G-MASLD HCC in MASLD Project
Assessment of characteristics of HCC in MASLD patients and development of models to predict outcomes.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
14G-MASLD Central Pathology Readout and Morphometry Project
Centralized reading of scanned liver biopsies by the central pathologist and quantification of collagen in these biopsies using morphometry techniques.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
13G-MASLD Burden of MetALD Project
Evaluation and comparison of MetALD patients with MASLD based on all available data (clinical, NIT, SNPs and outcomes).
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
12G-MASLD Lean MASLD Subproject
Assessment of characteristics, NITs and outcomes of Lean MASLD from the original Global MASLD cohort.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
11Ballooning of Hepatocytes and Long-Term Outcomes in MASLD Subproject
Using the G-MASLD project, assessment of the association between specific pathologic features and long-term outcomes in MASLD.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
10G-MASLD Outcomes Subproject
Determination of predictors of mortality and liver events in a large global cohort of MASLD.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
9G-MASLD NIT Performance Subproject
Performance of NITs in subpopulations such as diabetic and obese patients and other subgroups.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org
8Global-MASLD (G-MASLD) Original Project: (liver biopsy)
Enrolling patients with biopsy-proven MASLD, with clinical data, laboratory data, NITs and long-term outcomes data from over 40 sites across the globe.
Actively EnrollingLeyla deAvila
leyla.deavila@cldq.org

BIOMARKER PROJECTS

Project Title and DescriptionStatusProject Director
19PEth Testing in a Cohort of MASLD: Biomarker Project
Obtaining PEth results from sites across the globe for MASLD patients. The analysis will provide characteristics of these patients that can separate them from MASLD.
Actively EnrollingFatema Nader
fatema.nader@cldq.org

ECONOMIC ANALYSIS & META-ANALYSIS PROJECTS

Project Title and DescriptionStatusProject Director
23Cirrhosis in MASLD Meta-Analysis
Meta-analysis of currently available published studies on MASLD-related cirrhosis.
ActiveEliabe Abreu
22MASLD-Related HCC Meta-Analysis
Meta-analysis of currently available published studies on MASLD-related HCC.
ActiveEliabe Abreu
21Economic and Clinical Burden of MASH Among Those with Obesity (US, Germany, Spain, Brazil, Saudi Arabia, Japan, France, Italy & UK)
Assessment of clinical and economic burden (prevalence, number of cases, mortality, direct and indirect costs) in individuals with obesity from 9 countries.
ActiveJames Paik
20Economic and Clinical Burden of MASH Among Patients with T2D in 9 Countries
Assessment of clinical and economic burden (prevalence, number of cases, mortality, direct and indirect costs) in patients with diabetes from 9 countries.
ActiveJames Paik

TRANSPLANTATION

Project Title and DescriptionStatusProject Director
27Transplants for ALD: Liver Transplantation for Alcoholic Hepatitis vs. Cirrhosis — U.S. Registry Data
Using US transplant registries to assess characteristics and outcomes of patients receiving liver transplant with alcohol-associated liver disease.
Enrollment Closed
in Analyses
Maria Stepanova
26UNOS & ELITA Liver Transplantation Databases: Transplants for Hepatic Tumors (Malignant and Benign)
Using US and European registries to assess characteristics and outcomes of patients receiving liver transplant for liver tumors.
Enrollment Closed
in Analyses
Maria Stepanova
25UNOS & ELITA Liver Transplantation Databases: Transplantation for PBC and PSC
Using US and European registries to assess characteristics and outcomes of patients receiving liver transplant with PBC and PSC.
Enrollment Closed
in Analyses
Maria Stepanova
24UNOS & ELITA Liver Transplantation Databases: Hepatitis Delta and Liver Transplantation
Using US and European registries to assess characteristics and outcomes of patients receiving liver transplant with HDV.
Enrollment Closed
in Analyses
Maria Stepanova

EPIDEMIOLOGY AND POLICY PROJECTS RELATED TO SLD

Project Title and DescriptionStatusProject Director
28Global Nutrition Project: Validation of a Short UPF Questionnaire; Prospective Cohort on CMRFs & MASLD
Validation and utility of a newly developed short version of the UPF questionnaire.
ActiveDana Ivancovsky Wajcman
29Global Pathways Linking Alcohol Exposure, Food Systems, and Alcohol-Associated Liver DiseaseActiveDana Ivancovsky Wajcman
30Exercise, Activity and MASLD Outcomes: NHANES ProjectActiveJames Paik
31Long-Term Outcomes of MetALD & ALD in Youth (NHANES Restricted Data)ActiveJames Paik
32Development and Validation of Short Food Frequency QuestionnaireActiveDana Ivancovsky Wajcman
33Omics of MASLD: Analyzing Genomics, Proteomics, and Other Omics Data for 400–500 Patients from the US
Using previously collected data on SNPs, gene expression, miRNA, proteomics and metabolomics to better understand different aspects of MASLD.
Enrollment Closed
in Analyses
Maria Stepanova